Aug. 31, 2011
DENTSPLY International has completed the previously announced acquisition of Astra Tech AB.

YORK, Pennsylvania--DENTSPLY International, a leader in professional dental products, has announced completion of the previously announced acquisition of Astra Tech AB, a provider of dental implants, customized implant abutments, and urology and surgery products, from AstraZeneca.

Bret Wise, DENTSPLY's chairman and chief executive officer, said, "We are very pleased to complete the acquisition of Astra Tech AB and welcome the Astra Tech team to DENTSPLY. This transaction provides substantial benefits to DENTSPLY, including one of the fastest-growing dental implant platforms in the market and the addition of a growing and profitable health-care device business serving urology and surgical markets. We are excited about the opportunities that our combined business will bring to our customers, employees and shareholders."

DENTSPLY International receives regulatory approva

DENTSPLY anticipates this transaction will add approximately $200 million to the company's net sales in 2011, and $600 million on an annualized basis. DENTSPLY also expects the transaction will be neutral to slightly accretive to adjusted earnings per diluted share in 2011.

For more information, go to

To comment on this subject, go to